Metabolic Markers Demonstrate the Heterogeneity of Myosteatosis in Community-Dwelling Older Black Men from the Health ABC Study

Metabolic Markers Demonstrate the Heterogeneity of Myosteatosis in Community-Dwelling Older Black Men from the Health ABC Study

Myosteatosis is a complex condition, associated with aging and diverse pathological conditions (e.g., diabetes), that contributes to mobility disability. Improved characterization of myosteatosis is required to develop targeted interventions to maintain muscle health in aging. We first determined th...

Full description

Bibliographic Details
Main Authors:	Samaneh Farsijani, Megan M. Marron, Iva Miljkovic, Mary Elizabeth Baugh, Stephen B. Kritchevsky, Anne B. Newman
Format:	Article
Language:	English
Published:	MDPI AG 2021-04-01
Series:	Metabolites
Subjects:	myosteatosis metabolomics aging heterogeneity African American mobility
Online Access:	https://www.mdpi.com/2218-1989/11/4/224

Similar Items

Metabolites Associated with Vigor to Frailty Among Community-Dwelling Older Black Men
by: Megan M. Marron, et al.
Published: (2019-04-01)

Albumin‐myosteatosis gauge as a novel prognostic risk factor in patients with non‐metastatic colorectal cancer
by: Yerim Kim, et al.
Published: (2023-04-01)

Characterizing cancer‐associated myosteatosis: anatomic distribution and cancer‐specific variability of low radiodensity muscle
by: Victoria Armstrong, et al.
Published: (2021-07-01)

The effects of myosteatosis on skeletal muscle function in older adults
by: Kathleen Dondero, et al.
Published: (2024-05-01)

Association between atherogenic dyslipidemia and muscle quality defined by myosteatosis
by: Hwi Seung Kim, et al.
Published: (2024-08-01)

Quality Matters as Much as Quantity of Skeletal Muscle: Clinical Implications of Myosteatosis in Cardiometabolic Health
by: Hong-Kyu Kim, et al.
Published: (2021-12-01)

Prognostic Impact of Myosteatosis on Mortality in Hospitalized Patients with COVID-19
by: Min-Kyu Kang, et al.
Published: (2022-09-01)

Psoriasis Is Associated With Myosteatosis but Not Sarcopenia: A Case-Control Study
by: Xiaomei Chen, et al.
Published: (2021-10-01)

Clinical Application of Artificial Intelligence-Based Computed Tomography Analysis of Myosteatosis in Localized Renal Cell Carcinoma
by: Byeong Jin Kang, et al.
Published: (2024-11-01)

Prognostic impact of myosteatosis in patients with colorectal cancer: a systematic review and meta‐analysis
by: Chan Mi Lee, et al.
Published: (2020-10-01)

Correlation study on gut microbiota and myosteatosis in patients with liver cirrhosis
by: Ninghui Zhao, et al.
Published: (2025-02-01)

Varying clinical relevance of sarcopenia and myosteatosis according to age among patients with postoperative colorectal cancer
by: Hye Jung Cho, et al.
Published: (2024-07-01)

Progressive sarcopenia and myosteatosis predict prognosis of advanced HCC patients treated with immune checkpoint inhibitors
by: Mengchen Liu, et al.
Published: (2024-04-01)

Combined impact of myosteatosis and liver steatosis on prognosis in stage I–III colorectal cancer patients
by: Dong Hee Lee, et al.
Published: (2023-12-01)

Comment on ‘Myosteatosis and Muscle Loss Impact Liver Transplant Outcomes in Male Patients With Hepatocellular Carcinoma’ by Lu et al.
by: Aikaterini Kamiliou, et al.
Published: (2024-12-01)

Myosteatosis in a systemic inflammation‐dependent manner predicts favorable survival outcomes in locally advanced esophageal cancer
by: Camila T. B. Gabiatti, et al.
Published: (2019-11-01)

The Role of Frailty and Myosteatosis in Predicting All-Cause Mortality in Older Adults with Cancer
by: Efthymios Papadopoulos, et al.
Published: (2024-12-01)

Sarcopenia and myosteatosis at presentation adversely affect survival after esophagectomy for esophageal cancer
by: Srpcic Matevz, et al.
Published: (2020-03-01)

Myosteatosis in the Context of Skeletal Muscle Function Deficit: An Interdisciplinary Workshop at the National Institute on Aging
by: Rosaly Correa-de-Araujo, et al.
Published: (2020-08-01)

A dynamic association between myosteatosis and liver stiffness: Results from a prospective interventional study in obese patients
by: Maxime Nachit, et al.
Published: (2021-08-01)

THE FEATURES OF PREOPERATIVE MYOPENIA, MYOSTEATOSIS, AND PHYSICAL FUNCTION IN JAPANESE PATIENTS WITH GASTROINTESTINAL CANCER: A CROSS-SECTIONAL STUDY
by: Noriatsu Tatematsu, et al.
Published: (2023-10-01)

Sarcopenia and myosteatosis diagnostic tool for gastrointestinal cancer: creatinine to cystatin C ratio as evaluation marker
by: Hao Liu, et al.
Published: (2023-10-01)

SARC‐F as a screening tool to detect computed tomography‐based sarcopenia and myosteatosis among older adults with cancer
by: Daniel L. Hess, et al.
Published: (2023-11-01)

Myosteatosis rather than sarcopenia associates with non‐alcoholic steatohepatitis in non‐alcoholic fatty liver disease preclinical models
by: Maxime Nachit, et al.
Published: (2021-02-01)

RORα–GABP–TFAM axis alleviates myosteatosis with fatty atrophy through reinforcement of mitochondrial capacity
by: Hyeon‐Ji Kim, et al.
Published: (2024-04-01)

What is the functional impact of sarcopenia and myosteatosis three months after discharge to an intensive care population? A monocentric observational study
by: Margot Dressaire, et al.
Published: (2024-10-01)

Impact of Baseline Muscle Mass and Myosteatosis on the Development of Early Toxicity During First-Line Chemotherapy in Patients With Initially Metastatic Pancreatic Cancer
by: Sun Hong, et al.
Published: (2022-05-01)

Preoperative myosteatosis and perioperative serum chloride levels predict 180 day major complications after radical cystectomy
by: Wassapol Sornthai, et al.
Published: (2025-01-01)

Myosteatosis and bone marrow adiposity are not associated among postmenopausal women with fragility fractures
by: Sammy Badr, et al.
Published: (2023-06-01)

Myosteatosis is associated with poor physical fitness in patients undergoing hepatopancreatobiliary surgery
by: Malcolm A. West, et al.
Published: (2019-08-01)

CD3+/CD4+ cells combined with myosteatosis predict the prognosis in patients who underwent gastric cancer surgery
by: Zhongze Du, et al.
Published: (2024-08-01)

Associations Between Lipoprotein Subfractions and Area and Density of Abdominal Muscle and Intermuscular Adipose Tissue: The Multi-Ethnic Study of Atherosclerosis
by: Megan M. Marron, et al.
Published: (2021-09-01)

The coexistence of myosteatosis and the creatinine/cystatin C ratio are determinants of outcomes in cholangiocarcinoma patients undergoing curative surgery
by: Yan Liu, et al.
Published: (2024-04-01)

Myosteatosis as an independent risk factor for mortality after kidney allograft transplantation: a retrospective cohort study
by: Antoine Morel, et al.
Published: (2022-02-01)

Association of Visceral Fat Obesity, Sarcopenia, and Myosteatosis with Non-Alcoholic Fatty Liver Disease without Obesity
by: Hong-Kyu Kim, et al.
Published: (2023-10-01)

The role of recipient myosteatosis in graft and patient survival after deceased donor liver transplantation
by: Zoltan Czigany, et al.
Published: (2021-04-01)

Myosteatosis Significantly Predicts Persistent Dyspnea and Mobility Problems in COVID-19 Survivors
by: Rebecca De Lorenzo, et al.
Published: (2022-04-01)

Thr92Ala-DIO2 heterozygosity is associated with skeletal muscle mass and myosteatosis in patients with COVID-19
by: Fabyan Esberard de Lima Beltrão, et al.
Published: (2024-08-01)

Myosteatosis as a Prognostic Marker for Postoperative Mortality in Adult Patients Undergoing Surgery in General—A Systematic Review
by: Onno Emanuel den Os, et al.
Published: (2023-11-01)

Radiological assessment of skeletal muscle index and myosteatosis and their impact postoperative outcomes after liver transplantation
by: Petric Miha, et al.
Published: (2023-06-01)